{"id":94496,"date":"2025-05-12T15:13:23","date_gmt":"2025-05-12T15:13:23","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/94496\/"},"modified":"2025-05-12T15:13:23","modified_gmt":"2025-05-12T15:13:23","slug":"chikungunya-le-vaccin-developpe-par-valneva-pres-de-nantes-suspendu-pour-les-personnes","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/94496\/","title":{"rendered":"Chikungunya\u00a0: le vaccin, d\u00e9velopp\u00e9 par Valneva pr\u00e8s de Nantes, suspendu pour les personnes"},"content":{"rendered":"<p>Les \u00c9tats-Unis suspendent\u00a0l\u2019utilisation du vaccin vivant, att\u00e9nu\u00e9 \u00e0 dose unique, <a href=\"https:\/\/nantes.maville.com\/actu\/actudet_-chikungunya-valneva-fournit-40-000-doses-de-son-vaccin-a-la-reunion-_52716-6732686_actu.Htm\" target=\"_self\" rel=\"noopener\">contre le chikungunya de Valneva,<\/a> chez les personnes \u00e2g\u00e9es (plus de 60\u00a0ans), jusqu\u2019\u00e0 l\u2019ach\u00e8vement des enqu\u00eates en cours sur des effets ind\u00e9sirables graves signal\u00e9s. Cette mesure fait apr\u00e8s une d\u00e9cision identique (pour les plus de 65\u00a0ans, cette fois), d\u00e9j\u00e0 prise par la France et l\u2019Union europ\u00e9enne, apr\u00e8s un d\u00e9c\u00e8s suspect \u00e0 la R\u00e9union.<\/p>\n<p>Enc\u00e9phalite et complications<\/p>\n<p>Ces deux personnes \u00e2g\u00e9es avaient \u00e9t\u00e9 vaccin\u00e9es dans l\u2019\u00eele, frapp\u00e9e par une \u00e9pid\u00e9mie tr\u00e8s importante de chikungunya.\u00a0Un octog\u00e9naire a d\u00e9velopp\u00e9 une enc\u00e9phalite, que les autorit\u00e9s fran\u00e7aises jugent tr\u00e8s probablement li\u00e9e au vaccin, et un septuag\u00e9naire a subi des complications mortelles de sa maladie de Parkinson, un d\u00e9veloppement dont le lien avec la vaccination appara\u00eet moins certain.<\/p>\n<p>Valneva <strong>\u00ab\u00a0demeure engag\u00e9e \u00e0 respecter les normes<\/strong>\u00a0<strong>de s\u00e9curit\u00e9 les plus strictes et \u00e0 \u00e9changer de mani\u00e8re proactive avec les autorit\u00e9s sanitaires dans tous les territoires o\u00f9 le vaccin IXCHIQ \u00ae est approuv\u00e9<\/strong>\u00a0\u00bb, pr\u00e9cise dans un communiqu\u00e9 la soci\u00e9t\u00e9. Plus de 40\u00a0000\u00a0doses, de ce vaccin source d\u2019espoir, auraient \u00e9t\u00e9 utilis\u00e9es \u00e0 ce jour dans le monde entier.<\/p>\n<p>\u00c0 noter que la campagne de vaccination chez les personnes \u00e2g\u00e9es de 18 \u00e0 64\u00a0ans se poursuit \u00e0 La R\u00e9union, afin de lutter contre l\u2019\u00e9pid\u00e9mie actuelle de chikungunya. \u00c9pid\u00e9mie qui\u00a0a d\u00e9j\u00e0 frapp\u00e9 plusieurs dizaines de milliers de patients, et tu\u00e9 douze d\u2019entre eux.<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"Les \u00c9tats-Unis suspendent\u00a0l\u2019utilisation du vaccin vivant, att\u00e9nu\u00e9 \u00e0 dose unique, contre le chikungunya de Valneva, chez les personnes&hellip;\n","protected":false},"author":2,"featured_media":94497,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2818],"tags":[1111,11,20720,6443,20717,1777,674,1011,27,766,12,2636,3744,3762,25,20719,773,20718],"class_list":{"0":"post-94496","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nantes","8":"tag-actu","9":"tag-actualites","10":"tag-agees","11":"tag-chikungunya","12":"tag-developpe","13":"tag-eu","14":"tag-europe","15":"tag-fr","16":"tag-france","17":"tag-nantes","18":"tag-news","19":"tag-pays-de-la-loire","20":"tag-personnes","21":"tag-pres","22":"tag-republique-francaise","23":"tag-suspendu","24":"tag-vaccin","25":"tag-valneva"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114495514492530909","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/94496","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=94496"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/94496\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/94497"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=94496"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=94496"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=94496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}